首页> 外国专利> A CD37 Antibody derived from a murine monoclonal antibody

A CD37 Antibody derived from a murine monoclonal antibody

机译:源自鼠单克隆抗体的CD37抗体

摘要

Yhumanizados CD37 Antibody Chimeric and loscontienen Pharmaceutical compositions are useful for the treatment of B Cell malignancies and autoimmune diseases and inflamatoriasque involve B cells in their patologu00eda.1.An Antibody Molecule that binds to cd37humano and DEA) that is derived from a murine monoclonal antibody to Pori) is defined which includes a heavy chain variable Amino Acid Sequence shown in SEQ ID no: 2; ii) a variable light chain comprising a sequence of Minou00e1cidos shown in SEQ ID no: 4Deb) or from a Human Antibody does not recognize the Human mismoepu00edtopo of CD37 Antibody defined in (a) or that recognizes an epitope that is near or with the sesuperpone epitope; in which the Molecule is a anticuerpoquimu00e9rico or humanizado.2. antibody- a claim which the Antibody Molecule is a Chimeric Antibody heavy chain variable defined Pori) comprising an Amino Acid Sequence shown in SEQ ID no: 2; ii) a variable light chain comprising Amino Acid Sequence shown in SEQ ID no: 4, (iii) CAD Enas are heavy and Light Constant humano.3.)- A Antibody of claim 2, in that (i) The Constant heavy chain is a Chain lgg1, ii) The Constant Kappa light chain is a Chain.
机译:Yhumanizados CD37抗体嵌合体和loscontienen药物组合物可用于治疗B细胞恶性肿瘤和自身免疫性疾病,并且炎症反应在其patolog 1中涉及B细胞。一种与cd37humano和DEA结合的抗体分子,该分子衍生自鼠类单克隆抗体定义了针对Pori的抗体),其包括SEQ ID NO:2所示的重链可变氨基酸序列; ii)包含SEQ ID no:4Deb)中所示的Mino的序列或来自人抗体的可变轻链不识别(a)中定义的CD37抗体的人错配位或识别附近的表位或带有sesuperpone表位;其中分子是抗cuerpoquim u200e9rico或humanizado.2。 -抗体,其中抗体分子是包含SEQ ID no:2所示的氨基酸序列的嵌合抗体重链变量(Pori); ii)包含SEQ ID no:4中所示氨基酸序列的可变轻链,(iii)CAD Enas是重链,并且是轻常数人源抗体。)-权利要求2的抗体,其中(i)恒定重链是a链lgg1,ii)恒定Kappa轻链是一条链。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号